Resveratrol for Exudative Age-Related Macular Degeneration (AGED)
Influence of Resveratrol and Resvega Versus Placebo on Incidence of Bilateralisation of Exudative AMD: a Double Masked Prospective Study.
Sponsor: Poitiers University Hospital
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Poitiers University Hospital
A NA clinical study on AMD and Age-related Macular Degeneration, this trial is terminated or withdrawn. The trial is conducted by Poitiers University Hospital and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jul 2020 — Jan 2021 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Sep 2019 — Jul 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Sep 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Poitiers University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .